Davin Deb, True Marker Pharmaceuticals, Inc. Founder and CEO: “By combining GS1 US Standards with industrial-grade hardware, we offer an ‘Integrity-Focused’ distribution model where compliance and quality testing are digitally optimized for our clients.”

True Marker Pharmaceuticals, Inc. was founded in 2023 with a clear point of view and a hard-earned sense of urgency. After more than two decades inside healthcare operations, Founder and CEO Davin Deb had seen the same problem surface again and again: fragile pharmaceutical supply chains that left independent pharmacies exposed, underpowered, and overly dependent on systems they could not control. True Marker exists to change that equation. Headquartered in Phoenix, Arizona, the company was built as a response to real operational failures, not a theoretical market gap. Following his leadership of DSquared Pharmaceuticals, Deb set out to create an organization that could combine technical distribution expertise with vertical manufacturing capabilities under one roof. The goal was not simply to move product more efficiently, but to provide pharmacies and providers with transparent traceability into their medications come from, how they are handled, and how they are tracked at every step.

True Marker is designed as a full-cycle pharmaceutical partner. The company operates a vertically integrated model that brings together pharmaceutical manufacturing and DSCSA-compliant wholesale distribution. This structure allows True Marker to deliver high-quality generic and branded medications, along with private-label solutions, while maintaining tight control over sourcing, serialization, and regulatory compliance. In a market where opacity and disruption are common, traceability is treated as a core asset, not a box to check. Independent pharmacies, clinics, and healthcare providers are the company’s primary audience, and their autonomy is central to True Marker’s strategy. Rather than forcing customers into rigid systems, the company focuses on building a secure supply chain that supports long-term independence and resilience. Strategic partnerships with organizations such as LSPediA, PPSWG, and the Healthcare Distribution Alliance further strengthen that infrastructure, ensuring alignment with industry standards and data integrity requirements.

What ultimately sets True Marker apart is its insistence that distribution alone is not enough. Medication security today requires data, compliance, and manufacturing discipline working together. True Marker does not just ship pharmaceuticals. It provides the regulatory, technical, and operational backbone that protects them, so providers can focus on patient care instead of supply risk. In an industry where trust is everything, True Marker positions itself as a stabilizing force built for the realities of modern healthcare.

In conversation with Davin Deb, Founder and CEO of True Marker Pharmaceuticals, Inc.

How did you build the infrastructure to make compliance a value proposition?

We built it by viewing regulations as a floor, not a ceiling. With my background in founding DSquared and managing complex logistics, I knew that true ‘value’ for a pharmacy comes from peace of mind. We didn’t just add a refrigerator; we built a validated cold chain ecosystem. By combining GS1 US Standards with clinical-grade hardware, we offer an ‘Integrity-Focused’ distribution model where compliance and quality testing are digitally optimized for our clients.

How do you decide which products to prioritize for your distribution network?

Our priority is therapeutic necessity and supply chain security. We focus on products that independent pharmacies rely on for business continuity. For instance, we’ve prioritized the development and distribution of proprietary lines like CARBZAH, LURBIRO, and CLEMSZA. These products represent our commitment to maintaining a robust, dependable catalog across therapeutic categories.

How do exclusive partnerships influence your portfolio?

Exclusive partnerships are the cornerstone of our quality assurance. We choose partners who align with our mission of transparency and regulatory excellence. These relationships allow us to guarantee the pedigree of our inventory, ensuring that every product in our catalog—from generic essentials to our own private labels—is protected from the risks of diversion or counterfeiting.

How have you cultivated a culture of compliance and quality at True Marker?

Culture is about accountability. My background as a CEO and a founder has taught me that integrity is non-negotiable. We recently earned BBB Accreditation, which is a public reinforcement of our commitment to ethical business practices. We’ve also joined the Pharmaceutical Product Stewardship Work Group (PPSWG) to lead in safe medicine disposal. This culture of ‘doing the right thing’ is what I bring as CEO—it’s about building a brand that the healthcare community can trust implicitly.

How is True Marker responding to emerging healthcare trends such as regulatory shifts or the rise of specialty medicine?

We are proactive, not just reactive. Following our major facility expansion in September 2025, we took a massive leap forward by installing an industrial-grade, high-capacity walk-in refrigeration unit, which became fully operational at the end of January 2026. This was a strategic response to the unprecedented surge in demand for temperature-sensitive products, such as GLP-1 weight-loss therapies and other specialty medications. By building this infrastructure now, we are ensuring that independent pharmacies have a reliable, DSCSA-compliant partner capable of handling the most delicate products in the modern pharmacopeia.

Looking ahead, what innovations or new services are you most excited to unveil?

The launch of our ‘Cold Chain Hub’ is just the beginning. I am incredibly excited about our ability to provide validated precision—our systems are temperature-mapped and validated to exceed USP <1079> and FDA standards. This allows us to offer an expanded inventory of refrigerated brands and generics with a faster turnaround than traditional wholesalers. Our long-term vision is to marry this physical infrastructure with our LSPediA OneScan digital portal, giving our customers 100% visibility into both the pedigree and the environmental integrity of their life-saving shipments.

“We choose partners who align with our mission of transparency and regulatory excellence. These relationships allow us to guarantee the pedigree of our inventory, ensuring that every product in our catalog—from generic essentials to our own private labels—is protected from the risks of diversion or counterfeiting.”